Literature DB >> 21971819

Elevated soluble urokinase receptor values in CSF, age and bacterial meningitis infection are independent and additive risk factors of fatal outcome.

G Tzanakaki1, M Paparoupa, M Kyprianou, A Barbouni, J Eugen-Olsen, J Kourea-Kremastinou.   

Abstract

The aim of the present study was to evaluate the potential role of cerebrospinal fluid soluble urokinase receptor (suPAR) level, infection and age as risk factors for fatal outcome in patients suspected of having meningitis and/or bacteraemia on admission to hospital. A total of 545 cerebrospinal fluid samples from patients with clinically suspected meningitis were sent to the Hellenic National Meningitis Reference Laboratory. Ten of 545 (1.83%) patients died. Analysis by receiver operating characteristics (ROC) curve revealed that both suPAR and age were significant for prediction of fatal outcome. Patients with levels of suPAR above the cut-off values and age ≥ 51 years, or patients in which either Neisseria meningitis or Streptococcus pneumoniae were detected were categorized as high risk patients. The combination of the above three predictors (suPAR, age and infectious agent) in a logistic regression model with outcome of infection as the dependent variable yielded an overall odds ratio (OR = 85.7, 95% CI 10.6-690.2) with both sensitivity and specificity being equal to the value of 0.9. In conclusion, suPAR, age and type of infection have an additive effect in predicting mortality among patients suspected of meningitis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21971819     DOI: 10.1007/s10096-011-1423-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  26 in total

1.  Simultaneous single-tube PCR assay for the detection of Neisseria meningitidis, Haemophilus influenzae type b and Streptococcus pneumoniae.

Authors:  G Tzanakaki; M Tsopanomichalou; K Kesanopoulos; R Matzourani; M Sioumala; A Tabaki; J Kremastinou
Journal:  Clin Microbiol Infect       Date:  2005-05       Impact factor: 8.067

2.  Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome.

Authors:  Sisse R Ostrowski; Henrik Ullum; Bamenla Q Goka; Gunilla Høyer-Hansen; George Obeng-Adjei; Bente K Pedersen; Bartholomew D Akanmori; Jørgen A L Kurtzhals
Journal:  J Infect Dis       Date:  2005-03-14       Impact factor: 5.226

3.  Effects of intra-articular administration of sodium hyaluronate on plasminogen activator system in temporomandibular joints with osteoarthritis.

Authors:  Ya-ling Tang; Gui-quan Zhu; Lei Hu; Min Zheng; Jing-yi Zhang; Zong-dao Shi; Xin-hua Liang
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-02-24

4.  Urokinase-type plasminogen activator receptor regulates leukocyte recruitment during experimental pneumococcal meningitis.

Authors:  Robert Paul; Frank Winkler; Irene Bayerlein; Bernadette Popp; Hans-Walter Pfister; Uwe Koedel
Journal:  J Infect Dis       Date:  2005-01-25       Impact factor: 5.226

5.  Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection.

Authors:  N Sidenius; C F Sier; H Ullum; B K Pedersen; A C Lepri; F Blasi; J Eugen-Olsen
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

6.  Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients.

Authors:  Gian Matteo Rigolin; Alessia Tieghi; Maria Ciccone; Letizia Zenone Bragotti; Francesco Cavazzini; Matteo Della Porta; Barbara Castagnari; Rosanna Carroccia; Giovanni Guerra; Antonio Cuneo; Gianluigi Castoldi
Journal:  Br J Haematol       Date:  2003-03       Impact factor: 6.998

Review 7.  Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies.

Authors:  Rogier C J de Jonge; A Marceline van Furth; Merel Wassenaar; Reinoud J B J Gemke; Caroline B Terwee
Journal:  BMC Infect Dis       Date:  2010-08-05       Impact factor: 3.090

8.  Regulation of urokinase receptor function and pericellular proteolysis by the integrin alpha(5)beta(1).

Authors:  Rosemary Bass; Vincent Ellis
Journal:  Thromb Haemost       Date:  2009-05       Impact factor: 5.249

9.  Development of a single-tube polymerase chain reaction assay for the simultaneous detection of Haemophilus influenzae, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus spp. directly in clinical samples.

Authors:  Athanasia Xirogianni; Georgina Tzanakaki; Eleni Karagianni; Panayiotis Markoulatos; Jenny Kourea-Kremastinou
Journal:  Diagn Microbiol Infect Dis       Date:  2008-11-21       Impact factor: 2.803

10.  High mortality risk among individuals assumed to be TB-negative can be predicted using a simple test.

Authors:  Paulo Rabna; Andreas Andersen; Christian Wejse; Ines Oliveira; Victor Francisco Gomes; Maya Bonde Haaland; Peter Aaby; Jesper Eugen-Olsen
Journal:  Trop Med Int Health       Date:  2009-09       Impact factor: 2.622

View more
  11 in total

1.  Neutrophil-to-lymphocyte ratio in the differential diagnosis of acute bacterial meningitis.

Authors:  A-F A Mentis; M A Kyprianou; A Xirogianni; K Kesanopoulos; G Tzanakaki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-20       Impact factor: 3.267

2.  Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia.

Authors:  Hong Guo; Lan-Xia Zhou; Haizhen Ma; Bei Liu; Juan Cheng; Yun-Yun Ma; Li Zhao
Journal:  Oncol Lett       Date:  2017-05-10       Impact factor: 2.967

3.  Why high suPAR is not super--diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU.

Authors:  Alexander Koch; Frank Tacke
Journal:  Crit Care       Date:  2011-12-15       Impact factor: 9.097

4.  Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population.

Authors:  Thomas H Haupt; Thomas Kallemose; Steen Ladelund; Line Jh Rasmussen; Christian W Thorball; Ove Andersen; Charlotta Pisinger; Jesper Eugen-Olsen
Journal:  Biomark Insights       Date:  2014-12-16

5.  Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study.

Authors:  Xuan Liu; Yong Shen; Zhihua Li; Aihua Fei; Hairong Wang; Qinmin Ge; Shuming Pan
Journal:  BMC Anesthesiol       Date:  2016-07-29       Impact factor: 2.217

6.  Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients.

Authors:  Athanasios Chalkias; Angeliki Mouzarou; Evangelia Samara; Theodoros Xanthos; Eleni Ischaki; Ioannis Pantazopoulos
Journal:  Mol Diagn Ther       Date:  2020-10       Impact factor: 4.074

Review 7.  Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.

Authors:  Line Jee Hartmann Rasmussen; Jens Emil Vang Petersen; Jesper Eugen-Olsen
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

8.  Clinical value of plasma soluble urokinase-type plasminogen activator receptor levels in term neonates with infection or sepsis: a prospective study.

Authors:  Tania Siahanidou; Alexandra Margeli; Chrysanthi Tsirogianni; Stavroula Charoni; Maria Giannaki; Eustathios Vavourakis; Athina Charisiadou; Ioannis Papassotiriou
Journal:  Mediators Inflamm       Date:  2014-05-05       Impact factor: 4.711

9.  Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis.

Authors:  Jens Emil Vang Petersen; Thomas Kallemose; Karen D Barton; Avshalom Caspi; Line Jee Hartmann Rasmussen
Journal:  BMJ Open       Date:  2020-07-19       Impact factor: 2.692

10.  Artificial Intelligence in Differential Diagnostics of Meningitis: A Nationwide Study.

Authors:  Alexios-Fotios A Mentis; Irene Garcia; Juan Jiménez; Maria Paparoupa; Athanasia Xirogianni; Anastasia Papandreou; Georgina Tzanakaki
Journal:  Diagnostics (Basel)       Date:  2021-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.